TABLE 1.
Patient Characteristic | Number | Percentage |
---|---|---|
Age | Median: 57 | Range: 23–93 |
Sex | ||
Female | 154 | 47% |
Male | 172 | 53% |
Race | ||
White | 286 | 88% |
Other* | 40 | 12% |
Tumor grade (Ki-67 index)† | ||
Low (<3%) | 150 | 46% |
Intermediate (3%–20%) | 108 | 33% |
High (>20%) | 18 | 5.5% |
Tumors not Ki-67 labeled | 50 | 15% |
AJCC stage | ||
Ia | 86 | 26% |
Ib | 61 | 19% |
IIa | 32 | 10% |
IIb | 87 | 27% |
III | 0 | 0% |
IV | 59 | 18% |
ENETS | ||
I | 74 | 23% |
IIa | 54 | 16% |
IIb | 48 | 15% |
IIIa | 3 | 1% |
IIIb | 87 | 27% |
IV | 59 | 18% |
Patient developing a recurrence | 65 | 20% |
Patients undergoing reoperation | 44 | 17% |
Patients currently surviving | 235 | 72% |
22 Black, 2 Asian, 3 Hispanic ethnicity, 12 Other, and 1 Unknown.
According to ENETS and WHO designations.16